Overexpression of Mortalin in hepatocellular carcinoma and its relationship with angiogenesis and epithelial to mesenchymal transition

Chen,Jing; Liu,Wen-Bin; Jia,Wei-Dong; Xu,Ge-Liang; Ma,Jin-Liang; Huang,Mei; Deng,Yan-Ru; Li,Jian-Sheng

doi:10.3892/ijo.2013.2161

Overexpression of Mortalin in hepatocellular carcinoma and its relationship with angiogenesis and epithelial to mesenchymal transition

Authors:
- Jing Chen
- Wen-Bin Liu
- Wei-Dong Jia
- Ge-Liang Xu
- Jin-Liang Ma
- Mei Huang
- Yan-Ru Deng
- Jian-Sheng Li
View Affiliations

Affiliations: Department of Hepatic Surgery, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui 230001, P.R. China, Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui 230001, P.R. China, Laboratory of Emergency Medicine, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui 230001, P.R. China
Published online on: November 1, 2013 https://doi.org/10.3892/ijo.2013.2161
Pages: 247-255

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mortalin is highly expressed in a variety of human tumors and associated with tumor metastasis. However, the relationship among the overexpression of Mortalin, epithelial to mesenchymal transition (EMT) and neovascularization is largely unknown. The aim of the present study was to investigate the expression of Mortalin in human HCC cell lines, clinical HCC specimens and its association with angiogenesis and EMT. The results of our study showed that the expression levels of Mortalin in cell lines with higher metastatic potential were significantly higher compared to those with lower metastatic potential. Compared with paracarcinomatous tissues and normal liver tissues, the expression of Mortalin was significantly increased in HCC tumor tissues. The expression of Mortalin was correlated with invasion and metastasis, Edmondson grade and TNM stage. A significant positive correlation was found between the expression of Mortalin and Vimentin, and tumors with high expression of Mortalin had a tendency to higher MVD compared to those with low expression of Mortalin. Using shRNA-mediated Mortalin knockdown, we found that decreased expression of Mortalin was accompanied by a reduction of Vimentin expression. Our findings demonstrated that the overexpression of Mortalin is correlated with the metastatic phenotype of HCC cells and can promote EMT, but cannot induce angiogenesis in HCC. The decreased expression of Mortalin is accompanied by an inhibition of EMT in the HCC cell lines.

View Figures

View References

1.	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2.	Forner A, Llovet JM and Bruix J: Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar
3.	Polyak K and Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
4.	Christiansen JJ and Rajasekaran AK: Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 66:8319–8326. 2006. View Article : Google Scholar : PubMed/NCBI
5.	Tanaka S and Arii S: Molecular targeted therapies in hepatocellular carcinoma. Semin Oncol. 39:486–492. 2012. View Article : Google Scholar
6.	Wadhwa R, Taira K and Kaul SC: An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where? Cell Stress Chaperones. 7:309–316. 2002. View Article : Google Scholar : PubMed/NCBI
7.	Wadhwa R, Takano S, Kaur K, et al: Upregulation of mortalin/ mthsp70/Grp75 contributes to human carcinogenesis. Int J Cancer. 118:2973–2980. 2006. View Article : Google Scholar : PubMed/NCBI
8.	Mizukoshi E, Suzuki M, Misono T, et al: Cell-cycle dependent tyrosine phosphorylation on mortalin regulates its interaction with fibroblast growth factor-1. Biochem Biophys Res Commun. 280:1203–1209. 2001. View Article : Google Scholar : PubMed/NCBI
9.	Wadhwa R, Takano S, Robert M, et al: Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member. J Biol Chem. 273:29586–29591. 1998. View Article : Google Scholar : PubMed/NCBI
10.	Wadhwa R, Yaguchi T, Hasan MK, Taira K and Kaul SC: Mortalin-MPD (mevalonate pyrophosphate decarboxylase) interactions and their role in control of cellular proliferation. Biochem Biophys Res Commun. 302:735–742. 2003. View Article : Google Scholar : PubMed/NCBI
11.	Yi X, Luk JM, Lee NP, et al: Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol Cell Proteomics. 7:315–325. 2008. View Article : Google Scholar : PubMed/NCBI
12.	Li Y, Tang Y, Ye L, et al: Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol. 129:43–51. 2003.
13.	Li Y, Tang ZY, Ye SL, et al: Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol. 7:630–636. 2001.PubMed/NCBI
14.	Edmondson HA and Steiner PE: Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 7:462–503. 1954. View Article : Google Scholar : PubMed/NCBI
15.	Chen MH, Yip GW, Tse GM, et al: Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters. Mod Pathol. 21:1183–1191. 2008. View Article : Google Scholar : PubMed/NCBI
16.	Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
17.	Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002. View Article : Google Scholar : PubMed/NCBI
18.	Hartl FU: Molecular chaperones in cellular protein folding. Nature. 381:571–579. 1996. View Article : Google Scholar : PubMed/NCBI
19.	Calderwood SK, Khaleque MA, Sawyer DB and Ciocca DR: Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci. 31:164–172. 2006. View Article : Google Scholar : PubMed/NCBI
20.	Ma Z, Izumi H, Kanai M, Kabuyama Y, Ahn NG and Fukasawa K: Mortalin controls centrosome duplication via modulating centrosomal localization of p53. Oncogene. 25:5377–5390. 2006. View Article : Google Scholar : PubMed/NCBI
21.	Lu WJ, Lee NP, Kaul SC, et al: Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy. Cell Death Differ. 18:1046–1056. 2011. View Article : Google Scholar : PubMed/NCBI
22.	Dundas SR, Lawrie LC, Rooney PH and Murray GI: Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J Pathol. 205:74–81. 2005. View Article : Google Scholar : PubMed/NCBI
23.	Chen X, Xu B, Li H, et al: Expression of mortalin detected in human liver cancer by tissue microarrays. Anat Rec. 294:1344–1351. 2011. View Article : Google Scholar : PubMed/NCBI
24.	Kimura H, Nakajima T, Kagawa K, et al: Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry. Liver. 18:14–19. 1998. View Article : Google Scholar : PubMed/NCBI
25.	Gupta GP and Massague J: Cancer metastasis: building a framework. Cell. 127:679–695. 2006. View Article : Google Scholar : PubMed/NCBI
26.	Zhou Y, Mao H, Li S, et al: HSP72 inhibits Smad3 activation and nuclear translocation in renal epithelial-to-mesenchymal transition. J Am Soc Nephrol. 21:598–609. 2010. View Article : Google Scholar : PubMed/NCBI
27.	Li Y, Kang X and Wang Q: HSP70 decreases receptor-dependent phosphorylation of Smad2 and blocks TGF-beta-induced epithelial-mesenchymal transition. J Genet Genomics. 38:111–116. 2011. View Article : Google Scholar : PubMed/NCBI